BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

Achira Labs

Achira Labs logo

Website
https://achiralabs.com/
Founded
2009

Achira Labs is a immunodiagnostics company focussed on developing point-of-care diagnostics solutions for developing countries. Achira’s ACIX100 is a microfluidics platform which combines a plastic disposable cartridge containing dry reagents and a desktop reader instrument. ACIX100’s rapid turn around time, low costs and minimal infrastructure and manpower requirements make it very suitable for rural and semi-urban areas that are under-served by large centralised diagnostics labs. ACIX 100 has been clinically validated for 7 tests in thyroid and fertility, along with a large menu of tests including infectious diseases under development.

Achira leverages its expertise to provide technological services to customers in the medical devices sector. Achira’s expertise includes microfluidics research and development, design and prototyping, instrumentation, assay development and manufacturing. Achira is a 35 person company with a strong R&a;D focus. Achira has raised funds from Catamaran Ventures, Grand Challenges Canada and BIRAC (Govt. of India). Achira was founded in 2009 and is based in Bangalore, India.


Articles Mentioning This Company

The Quantum Drug Discovery Tracker

The Quantum Drug Discovery Tracker

Nov. 17, 2026     Articles
Latest changes · November 16, 2026 First edition as a living tracker, replacing our February 2024 article. 10 companies added. Roivant Discovery is now PsiThera, an independent company with a $47.5M Series A. Zapata shut down in October 2024 and is back as Zapata Quantum after a $15M round. Algorithmiq …

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.

Sign in or create an account